NASDAQ:VSCP - VirtualScopics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$4.04
Today's Range$4.04 - $4.04
52-Week Range$1.73 - $6.65
Average Volume34,573 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
VirtualScopics, Inc. is a provider of imaging services serving the pharmaceutical and biotechnology industries in early and late-stage clinical trials. The Company offers a range of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. Its image-based measurement and visualization tools enable reproducible measurement of minute changes that occur in anatomic structures in oncology, cardiology, neurology and musculoskeletal diseases. It has developed a system which enables the assessment of oncology patients per standard Response Evaluation Criteria in Solid Tumors criteria, while permitting the measurement of measures, including tumor volume, tumor metabolic rate through fluorodeoxyglucose-positron emission tomography and tumor mitotic rate through fluorodeoxyglucose-positron emission tomography or tumor cellular density through diffusion magnetic resonance imaging.

Receive VSCP News and Ratings via Email

Sign-up to receive the latest news and ratings for VSCP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Current SymbolNASDAQ:VSCP



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

VirtualScopics (NASDAQ:VSCP) Frequently Asked Questions

What is VirtualScopics' stock symbol?

VirtualScopics trades on the NASDAQ under the ticker symbol "VSCP."

Has VirtualScopics been receiving favorable news coverage?

News coverage about VSCP stock has been trending positive recently, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. VirtualScopics earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term.

What other stocks do shareholders of VirtualScopics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VirtualScopics investors own include SLS International (SLS), Micron Technology (MU), Acer Therapeutics (ACER), Novavax (NVAX), InspireMD (NSPR), InterCloud Systems (ICLD), Amarin (AMRN), Aralez Pharmaceuticals (ARLZ), Arena Pharmaceuticals (ARNA) and Aware (AWRE).

How do I buy shares of VirtualScopics?

Shares of VSCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is VirtualScopics' official website?

The official website for VirtualScopics is

How can I contact VirtualScopics?

VirtualScopics' mailing address is 500 Linden Oaks, ROCHESTER, NY 14625-2823, United States. The medical equipment provider can be reached via phone at +1-585-2496231.

MarketBeat Community Rating for VirtualScopics (NASDAQ VSCP)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  96
MarketBeat's community ratings are surveys of what our community members think about VirtualScopics and other stocks. Vote "Outperform" if you believe VSCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSCP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/23/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel